Arterys Partners with Avicenna.AI to Provide AI Stroke Detection

Arterys Partners with Avicenna.AI to Provide AI Stroke Detection

Arterys has fully integrated the CINA Head AI algorithms and will make them available via its FDA-cleared MICA platform to its installed base in the coming weeks.

Fremont, CA: Medical imaging AI specialist Avicenna.AI announced that its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging.

Arterys has fully integrated the CINA Head AI algorithms and will make them available via its FDA-cleared MICA platform to its installed base in the coming weeks. The platform's cloud SaaS model enables CINA Head's workflow-enhancing algorithms to be delivered instantly to any of Arterys' existing customers.

"Given CMS's recent NTAP reimbursement decision regarding AI-powered LVO detection, we believe that AI is finally ready to transform clinical practice, and we're excited to make Avicenna's AI innovations available to doctors around the world," said John Axerio-Cilies, Arterys co-founder and CEO. "We've tuned the experience for seamless workflow integration—towards the ends of efficient and effective analysis of non-contrast head CTs and CTAs and accurate detection of intracranial hemorrhages and LVO strokes."

Using a combination of deep learning and machine learning technologies, CINA Head automatically detects and prioritizes acute ICH and LVO cases within 20 seconds, seamlessly alerting the radiologist within their existing systems and workflow.

"Arterys's platform is the most agile in this new internet-based era of medical AI," said Cyril Di Grandi, co-founder, and CEO of Avicenna.AI. "They help companies like us go from code-to-clinic in weeks not years, giving radiologists the ability to instantly enhance their workflows with our AI – whenever they want to."